ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IPCIF IntelliPharmaCeutics International Inc (QB)

0.0213
-0.0787 (-78.70%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 242
Bid Price 0.0212
Ask Price 0.10
News -
Day High 0.10

Low
0.01

52 Week Range

High
0.135

Day Low 0.0213
Company Name Stock Ticker Symbol Market Type
IntelliPharmaCeutics International Inc (QB) IPCIF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0787 -78.70% 0.0213 16:09:14
Open Price Low Price High Price Close Price Prev Close
0.10 0.0213 0.10 0.0213 0.10
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3 242 $ 0.054092 $ 13 - 0.01 - 0.135
Last Trade Time Type Quantity Stock Price Currency
15:49:38 2 $ 0.08 USD

IntelliPharmaCeutics International Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 694.71k 32.62M 32.51M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IntelliPharmaCeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IPCIF Message Board. Create One! See More Posts on IPCIF Message Board See More Message Board Posts

Historical IPCIF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.03810.100.02130.05216763,460-0.0168-44.09%
1 Month0.060.100.02130.06132782,741-0.0387-64.50%
3 Months0.0470.1350.02130.06757419,533-0.0257-54.68%
6 Months0.04280.1350.02130.065168111,951-0.0215-50.23%
1 Year0.060.1350.010.068385411,931-0.0387-64.50%
3 Years0.180.29980.00120.109478311,595-0.1587-88.17%
5 Years0.26381.500.00120.310271657,092-0.2425-91.93%

IntelliPharmaCeutics (QB) Description

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company's abuse-deterrent oxycodone hydrochloride extended release formulation ("Oxycodone ER") based on its proprietary nPODDDS novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules).

Your Recent History

Delayed Upgrade Clock